Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

Endogenous cannabinoid anandamide impairs cell growth and induces apoptosis in chondrocytes.

Gómez R, Conde J, Scotece M, López V, Lago F, Gómez Reino JJ, Gualillo O.

J Orthop Res. 2014 Sep;32(9):1137-46. doi: 10.1002/jor.22660. Epub 2014 Jun 6.

2.

Anandamide induces cell death through lipid rafts in hepatic stellate cells.

Yang Q, Liu HY, Zhang YW, Wu WJ, Tang WX.

J Gastroenterol Hepatol. 2010 May;25(5):991-1001. doi: 10.1111/j.1440-1746.2009.06122.x. Epub 2010 Jan 4.

PMID:
20059638
3.

The endocannabinoid anandamide induces apoptosis in cytotrophoblast cells: involvement of both mitochondrial and death receptor pathways.

Costa MA, Fonseca BM, Teixeira NA, Correia-da-Silva G.

Placenta. 2015 Jan;36(1):69-76. doi: 10.1016/j.placenta.2014.10.011. Epub 2014 Nov 1.

PMID:
25465706
4.
5.

Anandamide-induced apoptosis in Chang liver cells involves ceramide and JNK/AP-1 pathway.

Giuliano M, Calvaruso G, Pellerito O, Portanova P, Carlisi D, Vento R, Tesoriere G.

Int J Mol Med. 2006 May;17(5):811-9.

PMID:
16596265
6.

ASK1-p38 MAPK/JNK signaling cascade mediates anandamide-induced PC12 cell death.

Sarker KP, Biswas KK, Yamakuchi M, Lee KY, Hahiguchi T, Kracht M, Kitajima I, Maruyama I.

J Neurochem. 2003 Apr;85(1):50-61.

7.

Proapoptotic effect of endocannabinoids in prostate cancer cells.

Orellana-Serradell O, Poblete CE, Sanchez C, Castellón EA, Gallegos I, Huidobro C, Llanos MN, Contreras HR.

Oncol Rep. 2015 Apr;33(4):1599-608. doi: 10.3892/or.2015.3746. Epub 2015 Jan 21.

8.

Evaluation of the role of the arachidonic acid cascade in anandamide's in vivo effects in mice.

Wiley JL, Razdan RK, Martin BR.

Life Sci. 2006 Dec 3;80(1):24-35. Epub 2006 Aug 23.

PMID:
16978656
9.

The endogenous cannabinoid anandamide is a lipid messenger activating cell growth via a cannabinoid receptor-independent pathway in hematopoietic cell lines.

Derocq JM, Bouaboula M, Marchand J, Rinaldi-Carmona M, Ségui M, Casellas P.

FEBS Lett. 1998 Apr 3;425(3):419-25.

10.

The Effects of the Endocannabinoids Anandamide and 2-Arachidonoylglycerol on Human Osteoblast Proliferation and Differentiation.

Smith M, Wilson R, O'Brien S, Tufarelli C, Anderson SI, O'Sullivan SE.

PLoS One. 2015 Sep 28;10(9):e0136546. doi: 10.1371/journal.pone.0136546. eCollection 2015.

11.

CB1 cannabinoid receptors couple to focal adhesion kinase to control insulin release.

Malenczyk K, Jazurek M, Keimpema E, Silvestri C, Janikiewicz J, Mackie K, Di Marzo V, Redowicz MJ, Harkany T, Dobrzyn A.

J Biol Chem. 2013 Nov 8;288(45):32685-99. doi: 10.1074/jbc.M113.478354. Epub 2013 Oct 2.

12.

[Anandamide inhibits the growth of colorectal cancer cells through CB1 and lipid rafts].

Liao YS, Wu J, Wang P, Zhang H.

Zhonghua Zhong Liu Za Zhi. 2011 Apr;33(4):256-9. Chinese.

PMID:
21575494
13.

Anandamide-induced cell death in primary neuronal cultures: role of calpain and caspase pathways.

Movsesyan VA, Stoica BA, Yakovlev AG, Knoblach SM, Lea PM 4th, Cernak I, Vink R, Faden AI.

Cell Death Differ. 2004 Oct;11(10):1121-32.

14.

Antiangiogenic activity of the endocannabinoid anandamide: correlation to its tumor-suppressor efficacy.

Pisanti S, Borselli C, Oliviero O, Laezza C, Gazzerro P, Bifulco M.

J Cell Physiol. 2007 May;211(2):495-503.

PMID:
17192847
15.

Anandamide-induced Ca2+ elevation leading to p38 MAPK phosphorylation and subsequent cell death via apoptosis in human osteosarcoma cells.

Hsu SS, Huang CJ, Cheng HH, Chou CT, Lee HY, Wang JL, Chen IS, Liu SI, Lu YC, Chang HT, Huang JK, Chen JS, Jan CR.

Toxicology. 2007 Feb 28;231(1):21-9. Epub 2006 Nov 11.

PMID:
17222495
16.

The endocannabinoid anandamide inhibits cholangiocarcinoma growth via activation of the noncanonical Wnt signaling pathway.

DeMorrow S, Francis H, Gaudio E, Venter J, Franchitto A, Kopriva S, Onori P, Mancinelli R, Frampton G, Coufal M, Mitchell B, Vaculin B, Alpini G.

Am J Physiol Gastrointest Liver Physiol. 2008 Dec;295(6):G1150-8. doi: 10.1152/ajpgi.90455.2008. Epub 2008 Oct 2.

17.

Effects of cannabinoids on nitric oxide production by chondrocytes and proteoglycan degradation in cartilage.

Mbvundula EC, Bunning RA, Rainsford KD.

Biochem Pharmacol. 2005 Feb 15;69(4):635-40. Epub 2005 Jan 7.

PMID:
15670582
18.

The MAP kinase signal transduction pathway is activated by the endogenous cannabinoid anandamide.

Wartmann M, Campbell D, Subramanian A, Burstein SH, Davis RJ.

FEBS Lett. 1995 Feb 13;359(2-3):133-6.

19.

Polyamine depletion inhibits apoptosis following blocking of survival pathways in human chondrocytes stimulated by tumor necrosis factor-alpha.

Stanic I, Facchini A, Borzì RM, Vitellozzi R, Stefanelli C, Goldring MB, Guarnieri C, Facchini A, Flamigni F.

J Cell Physiol. 2006 Jan;206(1):138-46.

PMID:
15965903
20.

Differential effects of tumor necrosis factor-alpha and interleukin-1beta on cell death in human articular chondrocytes.

Caramés B, López-Armada MJ, Cillero-Pastor B, Lires-Dean M, Vaamonde C, Galdo F, Blanco FJ.

Osteoarthritis Cartilage. 2008 Jun;16(6):715-22. Epub 2007 Nov 28.

Supplemental Content

Support Center